Brief: Stayble Therapeutics Engages Ferghana To Support Partnering Activities
Oct 24 (Reuters) - Stayble Therapeutics AB STABL.ST :
* STAYBLE THERAPEUTICS ENGAGES FERGHANA PARTNERS TO SUPPORT
PARTNERING ACTIVITIES
* TOPLINE RESULTS ARE EXPECTED TO BE PRESENTED IN NOVEMBER
OR
EARLY DECEMBER 2023
* HAS ENTERED AGREEMENT WITH FERGHANA FOR UPCOMING CLINICAL
RESULTS FROM THE PHASE 2B STUDY STA363
Source text for Eikon: ID:nWkr2M0d3G
Further company coverage: STABL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln